Search Tag: drug discovery

Executive Health Management

2024 01 Feb

Read more

IT Management

2023 02 Nov

The UK prime minister recently announced a new mission to accelerate the use of AI in life sciences to address today's major health challenges.   This funding will be targeted towards areas that AI has the greatest potential to create breakthroughs in treatments, as well as exploring how AI could address conditions with some of the highest mortality...Read more

Executive Health Management

2023 10 Sep

Read more

IT Management

2023 08 Jun

In another session at HIMSSEurope23, Noor Shaker, Senior Vice President, X-CHEM, talked about the different ways to analyse and identify different candidates at the early stage of drug discovery and to deliver those treatments to patients.   She discussed how healthcare is seeing great innovation in the AI space and how AI is transforming biology...Read more

IT Management

2023 07 Nov

Hybrid Event Find Financial Times On Social Media Read more

Executive Health Management

2022 16 Jun

Panorama Medicine,  a genomics and AI powered drug discovery company focusing on therapeutics for RNA splicing defects, appoints Dr. Haishan Xiong as Chief Executive Officer to lead the company in its quest to bring revolutionary drugs to patients. “We are thrilled to have Dr. Xiong join Panorama,” said Dr. Yi Xing, co-founder of Panorama....Read more

IT Management

2022 07 Nov

Hybrid Event Find Financial Times On Social Media Read more

IT Management

2022 11 May

Hybrid Event = In Person + Online Find Financial Times On Social Media Read more

Executive Health Management

2020 08 Jun

NOW A VIRTUAL EVENT DUE TO COVID-19 HEALTH CONCERNS Find Bio International Convention on Social Media Read more

Executive Health Management

2019 03 Jun

Find Bio International Convention on Social Media Read more

Executive Health Management

2019 22 May

The level of sophistication used in due diligence should be on par with the level of complexity in a given industry.  AI-Pharma companies are 100 times as complex as FinTech companies. Methodologies used to assess them should be 100 times as rigorous. Discovering new drugs using AI is one of the most challenging areas in biological...Read more